tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead doses first patient in ARO-DIMER-PA trial
The FlyArrowhead doses first patient in ARO-DIMER-PA trial
4d ago
ARWR
Arrowhead price target raised to $101 from $61 at B. Riley
PremiumThe Fly
Arrowhead price target raised to $101 from $61 at B. Riley
9d ago
ARWR
Arrowhead price target raised to $100 from $85 at H.C. Wainwright
PremiumThe Fly
Arrowhead price target raised to $100 from $85 at H.C. Wainwright
10d ago
ARWR
Arrowhead price target raised to $110 from $100 at Piper Sandler
PremiumThe Fly
Arrowhead price target raised to $110 from $100 at Piper Sandler
18d ago
ARWR
Arrowhead Pharmaceuticals Issues Zero-Coupon 2032 Convertible Notes
PremiumCompany Announcements
Arrowhead Pharmaceuticals Issues Zero-Coupon 2032 Convertible Notes
18d ago
8K
ARWR
Arrowhead’s ARO-DIMERPA Trial Advances in Mixed Hyperlipidemia: What Investors Should Watch
PremiumCompany AnnouncementsArrowhead’s ARO-DIMERPA Trial Advances in Mixed Hyperlipidemia: What Investors Should Watch
22d ago
ARWR
Arrowhead Pharmaceuticals Launches Major Equity and Notes Offerings
Premium
Company Announcements
Arrowhead Pharmaceuticals Launches Major Equity and Notes Offerings
22d ago
8K
ARWR
Arrowhead 3.1M share Secondary priced at $64.50
Premium
The Fly
Arrowhead 3.1M share Secondary priced at $64.50
23d ago
ARWR
Arrowhead announces China NMPA approval for Redemplo
PremiumThe Fly
Arrowhead announces China NMPA approval for Redemplo
24d ago
ARWR
Arrowhead price target raised to $85 from $50 at Goldman Sachs
PremiumThe Fly
Arrowhead price target raised to $85 from $50 at Goldman Sachs
24d ago
ARWR
Arrowhead price target raised to $81 from $48 at Morgan Stanley
PremiumThe Fly
Arrowhead price target raised to $81 from $48 at Morgan Stanley
24d ago
ARWR
Arrowhead price target raised to $80 from $60 at Chardan
PremiumThe Fly
Arrowhead price target raised to $80 from $60 at Chardan
24d ago
ARWR
Arrowhead announces offerings of convertible senior notes and common stock
PremiumThe FlyArrowhead announces offerings of convertible senior notes and common stock
24d ago
ARWR
Arrowhead Reports Promising Interim Data for Obesity RNAi Trials
Premium
Company Announcements
Arrowhead Reports Promising Interim Data for Obesity RNAi Trials
24d ago
8K
ARWR
Clear Street keeps Buy on Wave Life Sciences after Arrowhead data
Premium
The Fly
Clear Street keeps Buy on Wave Life Sciences after Arrowhead data
25d ago
WVE
ARWR
H.C. Wainwright says initial Phase 1/2a data de-risk Arrowhead obesity franchise
PremiumThe Fly
H.C. Wainwright says initial Phase 1/2a data de-risk Arrowhead obesity franchise
25d ago
ARWR
Arrowhead announces interim results from trials of ARO-INHBE, ARO-ALK7
PremiumThe Fly
Arrowhead announces interim results from trials of ARO-INHBE, ARO-ALK7
25d ago
ARWR
Arrowhead falls -8.5%
PremiumThe Fly
Arrowhead falls -8.5%
26d ago
ARWR
Arrowhead announces Health Canada approval of Redemplo
PremiumThe Fly
Arrowhead announces Health Canada approval of Redemplo
26d ago
ARWR
iBio initiated with an Outperform at LifeSci Capital
PremiumThe FlyiBio initiated with an Outperform at LifeSci Capital
1M ago
WVE
ARWR
Arrowhead price target raised to $100 from $70 at Piper Sandler
Premium
The Fly
Arrowhead price target raised to $100 from $70 at Piper Sandler
1M ago
ARWR
IONS
Arrowhead falls -10.4%
Premium
The Fly
Arrowhead falls -10.4%
2M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >